30 results on '"Malee,Kathleen"'
Search Results
2. Acylcarnitines and Genetic Variation in Fat Oxidation Genes in HIV-infected, Antiretroviral-treated Children With and Without Myopathy.
3. Racial/Ethnic Disparities in Longitudinal Emotional–Behavioral Functioning Among Youth Born to Women Living With HIV.
4. Racial/Ethnic Disparities in Longitudinal Emotional-Behavioral Functioning Among Youth Born to Women Living With HIV.
5. Neurodevelopment of HIV-Exposed Uninfected Infants Born to Women With Perinatally Acquired HIV in the United States.
6. Machine-learning classification of neurocognitive performance in children with perinatal HIV initiating de novo antiretroviral therapy.
7. Increased Risk of Executive Function and Emotional Behavioral Problems Among Virologically Well-Controlled Perinatally HIV-Infected Adolescents in Thailand and Cambodia.
8. Trajectory Analysis of Cognitive Outcomes in Children With Perinatal HIV.
9. Nonadherence and unsuppressed viral load across adolescence among US youth with perinatally acquired HIV.
10. Emotional and behavioral resilience among children with perinatally acquired HIV in Thailand and Cambodia.
11. Impact of Perinatally Acquired HIV Disease Upon Longitudinal Changes in Memory and Executive Functioning.
12. Roles of Medication Responsibility, Executive and Adaptive Functioning in Adherence for Children and Adolescents With Perinatally Acquired HIV.
13. Learning and Memory in Children and Adolescents With Perinatal HIV Infection and Perinatal HIV Exposure.
14. Stimulant Medications and Cognition, Behavior and Quality of Life in Children and Youth with HIV.
15. Default Mode Connectivity in Youth With Perinatally Acquired HIV.
16. Executive Functioning in Children and Adolescents With Perinatal HIV Infection.
17. White matter microstructure among youth with perinatally acquired HIV is associated with disease severity.
18. Early viral suppression improves neurocognitive outcomes in HIV-infected children.
19. Discordance of Cognitive and Academic Achievement Outcomes in Youth With Perinatal HIV Exposure.
20. Prevalence, Incidence, and Persistence of Psychiatric and Substance Use Disorders Among Mothers Living With HIV.
21. Biomarkers and neurodevelopment in perinatally HIV-infected or exposed youth: a structural equation model analysis.
22. Evaluation of Risk for Late Language Emergence After In Utero Antiretroviral Drug Exposure in HIV-exposed Uninfected Infants.
23. Safety of Perinatal Exposure to Antiretroviral Medications.
24. Impact of HIV Severity on Cognitive and Adaptive Functioning During Childhood and Adolescence.
25. Cognitive, academic, and behavioral correlates of medication adherence in children and adolescents with perinatally acquired HIV infection.
26. Language impairment in children perinatally infected with HIV compared to children who were HIV-exposed and uninfected.
27. Impact of medications prescribed for treatment of attention-deficit hyperactivity disorder on physical growth in children and adolescents with HIV.
28. Assessment of adherence to antiretroviral therapy in perinatally HIV-infected children and youth using self-report measures and pill count.
29. Timing of perinatal human immunodeficiency virus type 1 infection and rate of neurodevelopment.
30. Relationships between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youth.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.